| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/23/1999 | CA2323083A1 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | CA2322699A1 Compositions and methods for enhanced antigen delivery to antigen presenting cells in vivo |
| 09/23/1999 | CA2322660A1 Enhanced anti-tumor immunity |
| 09/23/1999 | CA2322659A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
| 09/23/1999 | CA2249662A1 Novel compounds |
| 09/22/1999 | EP0943685A2 G-protein coupled receptor from human brain |
| 09/22/1999 | EP0943684A2 Frizzled-like polypeptides and polynucleotides |
| 09/22/1999 | EP0943683A1 Human vanilloid receptor homologue Vanilrep1 |
| 09/22/1999 | EP0943680A1 Suicide gene therapy system for the treatment of brain tumours |
| 09/22/1999 | EP0943096A1 A PROTEIN PREPARATION THAT MEDIATES Ca2+ -DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF |
| 09/22/1999 | EP0943015A2 Method and apparatus for preparing sample cartridges for a particle acceleration device |
| 09/22/1999 | EP0943005A1 Tissue specific and target rna-specific ribozymes as antimicrobial therapeutics against microbial pathogens |
| 09/22/1999 | EP0943004A2 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth |
| 09/22/1999 | EP0943003A1 Insulin-like growth factor i (igf-i) expression system and methods of use |
| 09/22/1999 | EP0942995A1 Novel calpaines, production and use thereof |
| 09/22/1999 | EP0942987A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 09/22/1999 | EP0942983A2 $i(STREPTOCOCCUS PNEUMONIAE) ANTIGENS AND VACCINES |
| 09/22/1999 | EP0942981A1 Fibroblast growth factor-13 |
| 09/22/1999 | EP0942977A2 Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
| 09/22/1999 | EP0942975A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses |
| 09/22/1999 | EP0942970A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 09/22/1999 | EP0942934A2 Receptor tyrosine kinase genes |
| 09/22/1999 | EP0942933A1 Human kdel receptor |
| 09/22/1999 | EP0942757A2 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof |
| 09/22/1999 | EP0942755A2 Treatment of diabetes with transcription factor gene |
| 09/22/1999 | EP0620741B1 Cytotoxic drug therapy |
| 09/22/1999 | EP0449948B1 Grafting genetically modified cells to treat diseases of the central nervous system |
| 09/22/1999 | CN1229439A Fusion polypeptides comprising an IgE-binding domain and a HSA component, and their diagnostic and therapeutic uses |
| 09/22/1999 | CN1229436A Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 09/21/1999 | US5955593 BH3 interacting domain death agonist |
| 09/21/1999 | US5955591 Phosphotriester oligonucleotides, amidites and method of preparation |
| 09/21/1999 | US5955589 Gapped 2' modified oligonucleotides |
| 09/21/1999 | US5955571 Novel n-branched nucleic acids with non-ribose phosphate backbone; for use in controlling gene expression, antisense agents, viricides, diagnosis, and genetic engineering techniques |
| 09/21/1999 | US5955443 Treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a nucleic acid encoding a platelet endothelial cell adhesion molecule-1 (pecam-1; also known as cd31 antigen or endocam) protein are |
| 09/21/1999 | US5955442 Methods for treating respiratory disease |
| 09/21/1999 | US5955441 Genetic inhibition of complement mediated inflammatory response |
| 09/21/1999 | US5955366 Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins |
| 09/21/1999 | US5955365 Introducing polynucleotides into cells |
| 09/21/1999 | US5955357 In-vitro-derived human neutrophil precursor cells |
| 09/21/1999 | US5955355 Chromosome 18 marker |
| 09/21/1999 | US5955339 Human inositol monophosphatase H1 |
| 09/21/1999 | US5955338 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
| 09/21/1999 | US5955304 DivIB |
| 09/21/1999 | US5955299 For diagnosis and treatment of systemic lupus erythematosus; antisense agents |
| 09/21/1999 | US5955283 Dna probe useful in diagnosis of diseases related to ion transport in the central and or automonic neverous system; alzheimer's/parkindon's/huntington's diseases |
| 09/21/1999 | US5955279 Ataxia-telangiectasia: mutations in the ATM gene |
| 09/21/1999 | US5954706 Drug delivery |
| 09/20/1999 | CA2232812A1 Interleukin-1 receptor antagonist beta (il-1ra.beta.) |
| 09/16/1999 | WO1999046388A1 Nucleic acid enzyme showing allosteric rna-cleaving activity on target rna |
| 09/16/1999 | WO1999046385A2 Compositions and methods for the treatment and prevention of metastatic disorders |
| 09/16/1999 | WO1999046383A1 Human n-type calcium channel isoform and uses thereof |
| 09/16/1999 | WO1999046381A2 Human fgf gene and gene expression products |
| 09/16/1999 | WO1999046379A2 Human receptor proteins; related reagents and methods |
| 09/16/1999 | WO1999046376A1 Receptor from the superfamily of tnt-receptors from the human lung |
| 09/16/1999 | WO1999046375A2 Human nucleic acid sequences from prostate tissue |
| 09/16/1999 | WO1999046374A2 Human nucleic acid sequences from prostate tumour tissue |
| 09/16/1999 | WO1999046372A2 Ribozymes capable of inhibiting the expression of the ccr5 receptor |
| 09/16/1999 | WO1999046371A2 Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 09/16/1999 | WO1999046366A1 Uses for humane non-autologous mesenchymal stem cells |
| 09/16/1999 | WO1999046364A1 Vascular endothelial growth factor 2 |
| 09/16/1999 | WO1999046296A1 Ecr673: a 7-transmembrane g-protein coupled receptor |
| 09/16/1999 | WO1999046289A1 31 human secreted proteins |
| 09/16/1999 | WO1999046284A2 Molecules that home to various selected organs or tissues |
| 09/16/1999 | WO1999046282A1 Plasminogen-related gene b polypeptides |
| 09/16/1999 | WO1999046281A2 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | WO1999046275A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS) |
| 09/16/1999 | WO1999046274A1 Modified factor viii |
| 09/16/1999 | WO1999045966A1 Polynucleotide composition, method of preparation, and use thereof |
| 09/16/1999 | WO1999045965A1 Retrovirus-mediated gene transfer to skin |
| 09/16/1999 | WO1999045960A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 09/16/1999 | WO1999045959A1 Humanized antibody and uses thereof |
| 09/16/1999 | WO1999045944A1 Proapoptotic peptides, dependence polypeptides and methods of use |
| 09/16/1999 | WO1999045783A1 Producer cells for replication selective viruses in the treatment of malignancy |
| 09/16/1999 | WO1999036511A3 Feline immunodeficiency virus gene therapy vectors |
| 09/16/1999 | WO1999036440A3 Expression of fusion proteins |
| 09/16/1999 | WO1999035243A3 Extension of cellular lifespan, methods and reagents |
| 09/16/1999 | WO1999032633A8 Toxoplasma gondii proteins, corresponding nucleic acid molecules, and uses thereof |
| 09/16/1999 | WO1999032625A3 Nucleotide and protein sequence of mammastatin and methods of use |
| 09/16/1999 | WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 09/16/1999 | WO1999027123A9 Modified sv40 viral vectors |
| 09/16/1999 | WO1999015684A9 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 09/16/1999 | WO1999015657A3 53bp2 complexes |
| 09/16/1999 | DE19811194A1 New nucleic acid expressed at high level in normal prostatic tissue and encoded polypeptides, used to treat cancer and screen for therapeutic agents |
| 09/16/1999 | DE19811193A1 New nucleic acid expressed at high level in prostatic tumor tissue and encoded polypeptides, useful for treating cancer and screening for therapeutic agents |
| 09/16/1999 | DE19809978A1 New soluble member of tumor necrosis factor receptor family, useful for identification specific modulators and for treating disease e.g. tumors |
| 09/16/1999 | CA2421394A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421388A1 Novel poypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421375A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421372A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421364A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421345A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421333A1 Pro 351 polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421329A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421322A1 Pro703 polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421319A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421315A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2323787A1 Humanized antibody and uses thereof |
| 09/16/1999 | CA2323460A1 Plasminogen-related gene b polypeptides |